IP Library Granted Patent US 11,634,689
Granted Patent B2
US 11,634,689 · App. 16/689,898 · Granted Apr 25, 2023

Method and composition for inducing chondrogenesis or tenogenesis in mesenchymal stem cells

Inventors: Sarah Yolande Kristel Broeckx (Bocholt, BE); Jan Hilda Marie Jozef Spaas (Bocholt, BE)
Assignee: BOEHRINGER INGELHEIM VETERINARY MEDICINE BELGIUM
C12N5/0655C12N5/066C12N5/0663C12N5/0665C12N5/0668C12N2501/105C12N2501/115C12N2501/15C12N2502/137C12N2502/1352C12N2502/1358C12N2502/1382C12N2506/1369
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,634,689
App. No.
16/689,898
Granted
Apr 25, 2023
Kind
B2
Abstract

A cell medium for in vitro inducing chondrogenesis or tenogenesis in mesenchymal stem cells (MSCs). The medium is a glucose medium supplemented with at least one growth factor is chosen from the group of fibroblast growth factors (FGF) or the group of transforming growth factors (TGF), and the FGF or TGF is present in a total concentration of between 1 and 15 ng/ml. In both cases, IGF can be added to enhance the induction process. The use of the cell medium, a method for inducing isolated mesenchymal stem cells (MSCs) and a cell composition obtained by the method are also provided.

Claims (4)

1. A method for inducing chondrogenesis in mesenchymal stem cells (MSCs), comprising culturing said MSCs in an inducing cell medium, wherein said medium comprises a Dulbecco's Modified Eagle's Medium (DMEM) low glucose medium supplemented with transforming growth factor (TGF) TGFβ3, wherein the growth factor is present at a total concentration of between 1 and 15 ng/ml in said medium, and wherein said MSCs are seeded at a density of 2 to 30×10 3 MSCs/cm 2 , and wherein said medium comprises between 10% and 30% fetal bovine serum or fetal calf serum of the total volume of the cell medium, to thereby induce the chondrogenesis.

2. The method according to claim 1 , wherein said growth factor is present in a total concentration of between 2 and 10 ng/ml.

3. The method according to claim 1 , wherein said inducing cell medium further comprises a growth factor selected from the group consisting of insulin growth factor (IGF) IGF-I in a concentration of between 10 and 225 ng/ml.

4. The method according to claim 1 , wherein said MSCs are cultured for a period of 1-7 days in inducing medium.

Assignments (2)
CHANGE OF NAME Recorded Jun 6, 2022
From: GLOBAL STEM CELL TECHNOLOGY
To: BOEHRINGER INGELHEIM VETERINARY MEDICINE BELGIUM
Reel/Frame 060285/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2019
From: BROECKX, SARAH YOLANDE KRISTEL; SPAAS, JAN HILDA MARIE JOZEF
To: GLOBAL STEM CELL TECHNOLOGY
Reel/Frame 051265/0706 →
Continuity (2)
Division 15038172
Related Publication 20200095552A1 · Mar 26, 2020